Medtronic EVP Sells $1.0M in Ordinary Shares Under 10b5-1 Plan

Insider Transaction Overview

On October 15, 2026, Michael Marinaro, Executive Vice President and President of MedSurg and Americas at Medtronic plc ($MDT), executed an open-market sale of 10,420 ordinary shares at a price of $96.00 per share, resulting in total transaction proceeds of approximately $1,000,320.

Transaction Details

• Security: Ordinary Shares
• Nature: Open Market Sale (Code: S)
• Shares Disposed: 10,420
• Execution Price: $96.00
• Remaining Direct Ownership: 105,916 shares
• Ownership Reduction: ~8.95% of prior direct holdings

Trading Plan Context & Significance

• Pre-Arranged 10b5-1 Plan: The filing explicitly notes that the sale was carried out pursuant to a pre-established Rule 10b5-1 trading plan adopted on March 17, 2026.
• Significance Rating: Low. Routine programmatic sales executed under a pre-established Rule 10b5-1 plan generally reflect planned liquidity or diversification rather than a discretionary perspective on near-term corporate performance. Marinaro continues to retain a substantial holding of 105,916 shares.